⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19187064 | 0.77 | — | — | |
| SCHEMBL7932079 | 0.77 | — | — | |
| SCHEMBL18630012 | 0.77 | — | — | |
| SCHEMBL19636807 | 0.74 | — | — | |
| SCHEMBL19386610 | 0.72 | — | — | |
| SCHEMBL27307315 | 0.72 | — | — | |
| SCHEMBL14066477 | 0.72 | LMNA (0.32) | — | |
| SCHEMBL19215823 | 0.71 | — | — | |
| SCHEMBL23616902 | 0.71 | TDP1 (0.38) | — | |
| SCHEMBL16312710 | 0.71 | SOAT1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240238324-A1 | HIGHLY ACTIVE COMPOUNDS AGAINST COVID-19 | Atea Pharmaceuticals, Inc. (US) | 2024-07-18 | — | — | US | disclosed |
| US-11707480-B2 | Highly active compounds against COVID-19 | Atea Pharmaceuticals, Inc. (US) | 2023-07-25 | — | — | US | disclosed |